Special Issue "Tumour Angiogenesis"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (30 April 2013)
Dr. Ruowen Ge
Department of Biological Sciences, National University of Singapore, 14 Science Drive 4, 117543, Singapore
Interests: angiogenesis; cancer microenvironment; anti-angiogenic proteins; endothelial cell biology; hepatogenesis
Tumor angiogenesis is critical for both tumor progression and metastasis. Hence targeting tumor angiogenesis as a therapeutic anticancer approach has been actively pursued for many years. Despite the initial success in animal tumor models and some degree of effectiveness in prolonging the survival of human cancer patients, limitations of efficacy plus inherent as well as acquired resistance in human cancers still plague this therapeutic approach. Hence, further understanding of the molecular and cellular mechanisms of tumor angiogenesis are essential for the advancement of effective antiangiogenic therapy. This special issue will focus on new advancement in the biology and drug targeting of tumor angiogenesis.
We are looking forward to your contributions.
Dr. Ruowen Ge
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed Open Access quarterly journal published by MDPI.
- tumor angiogenesis regulator
- tumor vasculogenesis
- signaling pathways
- antiangiogenic drug resistance
- pericytes and vessel structure
- vessel integrity
- vascular permeability
- endothelial cell junctions
- tumor microenvironment
- tumor angiogenesis markers
Review: Critical Role of Aberrant Angiogenesis in the Development of Tumor Hypoxia and Associated Radioresistance
Cancers 2014, 6(2), 813-828; doi:10.3390/cancers6020813
Received: 7 February 2014; in revised form: 18 March 2014 / Accepted: 21 March 2014 / Published: 8 April 2014| PDF Full-text (502 KB) | HTML Full-text | XML Full-text
Cancers 2013, 5(3), 1140-1162; doi:10.3390/cancers5031140
Received: 5 July 2013; in revised form: 23 July 2013 / Accepted: 30 August 2013 / Published: 6 September 2013| Cited by 2 | PDF Full-text (663 KB) | HTML Full-text | XML Full-text | Supplementary Files
Review: Influence of Levamisole and Other Angiogenesis Inhibitors on Angiogenesis and Endothelial Cell Morphology in Vitro
Cancers 2013, 5(3), 762-785; doi:10.3390/cancers5030762
Received: 23 April 2013; in revised form: 11 June 2013 / Accepted: 14 June 2013 / Published: 24 June 2013| PDF Full-text (634 KB) | HTML Full-text | XML Full-text
Cancers 2013, 5(2), 726-738; doi:10.3390/cancers5020726
Received: 3 May 2013; in revised form: 31 May 2013 / Accepted: 7 June 2013 / Published: 19 June 2013| Cited by 3 | PDF Full-text (741 KB) | HTML Full-text | XML Full-text
Cancers 2012, 4(4), 1252-1299; doi:10.3390/cancers4041252
Received: 22 October 2012; in revised form: 21 November 2012 / Accepted: 23 November 2012 / Published: 29 November 2012| PDF Full-text (1259 KB) | HTML Full-text | XML Full-text
Cancers 2012, 4(3), 846-872; doi:10.3390/cancers4030846
Received: 24 May 2012; in revised form: 28 July 2012 / Accepted: 21 August 2012 / Published: 3 September 2012| Cited by 1 | PDF Full-text (246 KB) | HTML Full-text | XML Full-text
Last update: 8 October 2012